Hypoxia-inducible proto-oncogene Pim-1 is a prognostic marker in pancreatic ductal adenocarcinoma

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Cancer Biology & Therapy

• Publication date

  2008-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.4161/cbt.7.9.6418PMID 18708761
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The activated stroma index is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma.

  2008cited by this paper
• Adrenomedullin is induced by hypoxia and enhances pancreatic cancer cell invasion

  2007cited by this paper
• Overexpression of Pim-1 in head and neck squamous cell carcinomas.

  2007cited by this paper
• Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity.

  2007cited by this paper
• Overexpression of c‐myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathway

  2006cited by this paper
• Overexpression of Pim-1 during progression of prostatic adenocarcinoma

  2006cited by this paper
• The neurotrophic factor artemin influences the extent of neural damage and growth in chronic pancreatitis

  2006cited by this paper
• Pim-1 kinase expression during murine mammary development.

  2006cited by this paper
• Loss of BNIP3 expression is a late event in pancreatic cancer contributing to chemoresistance and worsened prognosis

  2005cited by this paper
• The serine/threonine kinase Pim-1.

  2005cited by this paper
• Expression of hypoxia‐inducible factors is correlated with the presence of a fibrotic focus and angiogenesis in pancreatic ductal adenocarcinomas

  2005cited by this paper
• Mice Deficient for All PIM Kinases Display Reduced Body Size and Impaired Responses to Hematopoietic Growth Factors

  2004cited by this paper
• Pim‐1 kinase promotes inactivation of the pro‐apoptotic Bad protein by phosphorylating it on the Ser112 gatekeeper site

  2004cited by this paper
• [Pim-1 induced by hypoxia is involved in drug resistance and tumorigenesis of solid tumor cells].

  2004cited by this paper
• Overexpression of the oncogenic kinase Pim-1 leads to genomic instability.

  2003cited by this paper
• Protein Phosphatase 2A Regulates the Stability of Pim Protein Kinases*

  2003cited by this paper
• Hypoxia — a key regulatory factor in tumour growth

  2002cited by this paper
• Phosphorylation of the cell cycle inhibitor p21Cip1/WAF1 by Pim-1 kinase.

  2002cited by this paper
• Cutting Edge: Transcriptional Activity of NFATc1 Is Enhanced by the Pim-1 Kinase1

  2002cited by this paper
• Pim-1: a serine/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis.

  2001cited by this paper
• Delineation of prognostic biomarkers in prostate cancer

  2001cited by this paper
• Identification of heterochromatin protein 1 (HP1) as a phosphorylation target by Pim‐1 kinase and the effect of phosphorylation on the transcriptional repression function of HP1 1

  2000cited by this paper
• Pancreatic tumors show high levels of hypoxia.

  2000cited by this paper
• Physical and Functional Interactions between Pim-1 Kinase and Cdc25A Phosphatase

  1999cited by this paper
• TNM Classification of Malignant Tumors

  1998cited by this paper
• Pim-1 kinase and p100 cooperate to enhance c-Myb activity.

  1998cited by this paper
• Identification, culture, and characterization of pancreatic stellate cells in rats and humans.

  1998cited by this paper
• Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc

  1997cited by this paper
• Murine pancreatic ductal adenocarcinoma produced by in vitro transduction of polyoma middle T oncogene into the islets of Langerhans.

  1994cited by this paper
• The pim‐1 oncogene encodes two related protein‐serine/threonine kinases by alternative initiation at AUG and CUG.

  1991cited by this paper
• Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging.

  1991cited by this paper
• Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors.

  1989cited by this paper
• The primary structure of the putative oncogene pim-1 shows extensive homology with protein kinases.

  1986cited by this paper

• PIM1 kinase and its diverse substrate in solid tumors

  2024cites this paper
• Hypercapnic Tissue Gene Expression and Survival in Early-Stage Pancreatic Ductal Adenocarcinoma.

  2023cites this paper
• AUM302, a novel triple kinase PIM/PI3K/mTOR inhibitor, is a potent in vitro pancreatic cancer growth inhibitor

  2023cites this paper
• Relationship between the transcriptional expression of PIM1 and local control in patients with head and neck squamous cell carcinomas treated with radiotherapy

  2022cites this paper
• PIM1/STAT3 axis: a potential co-targeted therapeutic approach in triple-negative breast cancer

  2022cites this paper
• Clinical Significance of Pim-1 in Human Cancers: A Meta-analysis of Association with Prognosis and Clinicopathological Characteristics

  2022cites this paper
• Targeting DNA topoisomerase IIα (TOP2A) in the hypoxic tumour microenvironment using unidirectional hypoxia‐activated prodrugs (uHAPs)

  2022cites this paper
• Heme Oxygenase-1 Inhibition Potentiates the Effects of Nab-Paclitaxel-Gemcitabine and Modulates the Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma

  2021cites this paper
• Human amniotic mesenchymal stem cells to promote/suppress cancer: two sides of the same coin

  2021cites this paper
• Co-Targeting PIM Kinase and PI3K/mTOR in NSCLC

  2021cites this paper
• A New Compound with Increased Antitumor Activity by Cotargeting MEK and Pim-1

  2020cites this paper
• Pim1 Maintains Telomere Length in Mouse Cardiomyocytes by Inhibiting TGFβ Signaling.

  2020cites this paper
• Bidirectional and Opposite Effects of Naïve Mesenchymal Stem Cells on Tumor Growth and Progression

  2019cites this paper
• PIM1 kinase promotes cell proliferation, metastasis and tumor growth of lung adenocarcinoma by potentiating the c-MET signaling pathway.

  2019cites this paper
• Enhancing responsiveness of pancreatic cancer cells to gemcitabine treatment under hypoxia by heme oxygenase‐1 inhibition

  2019cites this paper
• PIM-1 kinase: a potential biomarker of triple-negative breast cancer

  2019cites this paper
• C-reactive protein (CRP) promotes malignant properties in pancreatic neuroendocrine neoplasms

  2019cites this paper
• RETRACTED ARTICLE: Resibufogenin suppresses tumor growth and inhibits glycolysis in ovarian cancer by modulating PIM1

  2019cites this paper
• A review on PIM kinases in tumors

  2019cites this paper
• Deoxynucleosides with benzimidazoles as aglycone moiety are potent anticancer agents

  2018cites this paper
• PIM1 mediates epithelial-mesenchymal transition by targeting Smads and c-Myc in the nucleus and potentiates clear-cell renal-cell carcinoma oncogenesis

  2018cites this paper
• PIM 1 KINASE IN ENDOTHELIAL CELL PROLIFERATION AND ADHESION

  2018cites this paper
• Hispidulin suppresses cell growth and metastasis by targeting PIM1 through JAK2/STAT3 signaling in colorectal cancer

  2018cites this paper
• PIM1 knockdown inhibits cell proliferation and invasion of mesothelioma cells.

  2017cites this paper
• Non-invasively predicting differentiation of pancreatic cancer through comparative serum metabonomic profiling

  2017cites this paper
• The role of Pim-1 in breast cancer metastasis

  2017cites this paper
• A positive feedback loop between Pim-1 kinase and HBP1 transcription factor contributes to hydrogen peroxide-induced premature senescence and apoptosis

  2017cites this paper
• Structure based drug design of Pim-1 kinase followed by pharmacophore guided synthesis of quinolone-based inhibitors.

  2017cites this paper
• Focused ultrasound for immuno-adjuvant treatment of pancreatic cancer: An emerging clinical paradigm in the era of personalized oncotherapy

  2017cites this paper
• Hypoxia, invasion and metastasis in pancreatic cancer

  2017cites this paper
• Low tristetraprolin expression promotes cell proliferation and predicts poor patients outcome in pancreatic cancer

  2016cites this paper
• Hypoxia‐responsive miR‐124 and miR‐144 reduce hypoxia‐induced autophagy and enhance radiosensitivity of prostate cancer cells via suppressing PIM1

  2016cites this paper
• Association of Nuclear PIM1 Expression with Lymph Node Metastasis and Poor Prognosis in Patients with Lung Adenocarcinoma and Squamous Cell Carcinoma

  2016cites this paper
• The role of PIM1/PIM2 kinases in tumors of the male reproductive system

  2016cites this paper
• The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cells

  2016cites this paper
• PIM1 polymorphism and PIM1 expression as predisposing factors of esophageal squamous cell carcinoma in the Asian population

  2016cites this paper
• Expression and function of PIM kinases in osteosarcoma.

  2016cites this paper
• Differential microRNA expression profiling of mesothelioma and expression analysis of miR-1 and miR-214 in mesothelioma.

  2016cites this paper
• PIM-1 contributes to the malignancy of pancreatic cancer and displays diagnostic and prognostic value

  2016influential citation
• Computational prediction and experimental validation of a novel synthesized pan-PIM inhibitor PI003 and its apoptosis-inducing mechanisms in cervical cancer

  2015cites this paper
• The novel combination of dual mTOR inhibitor AZD2014 and pan-PIM inhibitor AZD1208 inhibits growth in acute myeloid leukemia via HSF pathway suppression

  2015cites this paper
• Loss of PIM2 enhances the anti-proliferative effect of the pan-PIM kinase inhibitor AZD1208 in non-Hodgkin lymphomas

  2015cites this paper
• Role of pancreatic stellate cells and periostin in pancreatic cancer progression

  2015cites this paper
• PIM kinase (and Akt) biology and signaling in tumors.

  2015cites this paper
• Pim1 kinase is upregulated in glioblastoma multiforme and mediates tumor cell survival.

  2015cites this paper
• Carcinogenicity of Perfluoroalkyl Compounds

  2015cites this paper
• Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies.

  2014cites this paper
• PIM kinases: an overview in tumors and recent advances in pancreatic cancer.

  2014cites this paper
• PIM and AKT kinase inhibitors show synergistic cytotoxicity in acute myeloid leukaemia that is associated with convergence on mTOR and MCL1 pathways

  2014cites this paper
• The PIM Family of Serine/Threonine Kinases in Cancer

  2014cites this paper
• Exploiting Cell Cycle Pathways in Cancer Therapy: New (and Old) Targets and Potential Strategies

  2014cites this paper
• PIM1 kinase as a target in prostate cancer: roles in tumorigenesis, castration resistance, and docetaxel resistance.

  2014cites this paper
• Carcinogenesis & Mutagenesis Pim 1 Kinase Cooperates with Hormone Treatment to Promote Bladder and Ureteral Urothelial Hyperplasia

  2014cites this paper
• Atlas of Genetics and Cytogenetics in Oncology and Haematology

  2014cites this paper
• βIII-Tubulin: A novel mediator of chemoresistance and metastases in pancreatic cancer

  2014cites this paper
• PIM-1 modulates cellular senescence and links IL-6 signaling to heterochromatin formation

  2014cites this paper
• Etude de la stabilité et des mécanismes d'action de la protéine kinase oncogénique Pim-2 dans la Leucémie Aigüe Myéloïde

  2014cites this paper
• Pim1 Kinase Cooperates with Hormone Treatment to Promote Bladder and Ureteral Urothelial Hyperplasia

  2014cites this paper
• PIM1 (pim-1 oncogene)

  2013cites this paper
• Expression of pim-1 in Tumors, Tumor Stroma and Tumor-Adjacent Mucosa Co-Determines the Prognosis of Colon Cancer Patients

  2013cites this paper
• Decreased levels of circulating and tissue miR-107 in human esophageal cancer

  2013cites this paper
• Inhibition of oncogenic Pim-3 kinase modulates transformed growth and chemosensitizes pancreatic cancer cells to gemcitabine

  2013cites this paper
• Cell and gene therapy for severe heart failure patients: The time and place for Pim-1 kinase

  2013cites this paper
• Prognostic Significance of Extracellular Matrix Degrading Enzymes—Cathepsin L and Matrix Metalloproteases-2 [MMP-2] in Human Pancreatic Cancer

  2013cites this paper
• Pim kinases in cancer: diagnostic, prognostic and treatment opportunities.

  2013cites this paper
• Inhibition of the Pim1 Oncogene Results in Diminished Visual Function

  2012cites this paper
• Pancreatic Ductal Adenocarcinoma

  2012cites this paper
• Pim-1 knockdown potentiates paclitaxel-induced apoptosis in human hormone-refractory prostate cancers through inhibition of NHEJ DNA repair.

  2012cites this paper
• In-vitro investigation on the role of pancreatic stellate cells and tumor cells in angiogenesis

  2012cites this paper
• The impact of the activated stroma on pancreatic ductal adenocarcinoma biology and therapy resistance.

  2012cites this paper
• PIM 1 kinase as a target for cancer therapy

  2012cites this paper
• IL-6 Stimulates STAT3 and Pim-1 Kinase in Pancreatic Cancer Cell Lines

  2012cites this paper
• In vivo elucidation of PIM kinase role in tumourigenesis

  2012cites this paper
• PIM1 kinase as a target for cancer therapy

  2012cites this paper
• PIM1 gene cooperates with human BCL6 gene to promote the development of lymphomas

  2012cites this paper
• In-vitro Investigation on the Role of Pancreatic Stellate Cells and Tumor Cells in Angiogenesis

  2012cites this paper
• Pathology of pancreatic stroma in PDAC

  2012cites this paper
• The role of stroma in pancreatic cancer: diagnostic and therapeutic implications

  2012cites this paper
• Factors Affecting Cancer Behavior with Special Reference to Lymphatic Vessels, Macrophages, EGFR, and Pim-1 in Colorectal Cancer

  2012influential citation
• Systems Biology of Pancreatic Cancer: The Role of Tumor-Microenvironment Communication in Development, Progression and Therapy Resistance

  2012cites this paper
• MUC1 Regulates PDGFA Expression During Pancreatic Cancer Progression

  2012cites this paper
• Pigment Epithelium-Derived Factor Associates With Neuropathy and Fibrosis in Pancreatic Cancer

  2011cites this paper
• Identification of HIF2alpha as an important STAT5 target gene in human hematopoietic stem cells.

  2011cites this paper
• Glutamate increases pancreatic cancer cell invasion and migration via AMPA receptor activation and Kras‐MAPK signaling

  2011cites this paper
• For better or for worse: the role of Pim oncogenes in tumorigenesis

  2011cites this paper
• Implication de la voie de signalisation Src/Stat3 dans l'étiologie de l'hypertension artérielle pulmonaire

  2011cites this paper
• ERG Deregulation Induces PIM1 Over-Expression and Aneuploidy in Prostate Epithelial Cells

  2011cites this paper
• The oncogenic kinase Pim-1 is modulated by K-Ras signaling and mediates transformed growth and radioresistance in human pancreatic ductal adenocarcinoma cells.

  2011cites this paper
• PIM2 inhibition as a rational therapeutic approach in B-cell lymphoma.

  2011cites this paper
• Identification of HIF 2 as an important STAT 5 target gene in human hematopoietic stem cells

  2011cites this paper
• Pancreatic Cancer: The Role of Pancreatic Stellate Cells in Tumor Progression

  2011cites this paper
• Why target PIM1 for cancer diagnosis and treatment?

  2010cites this paper
• PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers

  2010cites this paper
• Hypoxia Induced Tumor Metabolic Switch Contributes to Pancreatic Cancer Aggressiveness

  2010cites this paper
• Organ-, inflammation- and cancer specific transcriptional fingerprints of pancreatic and hepatic stellate cells

  2010cites this paper
• Overexpression of Pim‐1 is associated with poor prognosis in patients with esophageal squamous cell carcinoma

  2010cites this paper
• A pivotal role for Pim-1 kinase in esophageal squamous cell carcinoma involving cell apoptosis induced by reducing Akt phosphorylation.

  2010cites this paper
• Stromal biology and therapy in pancreatic cancer

  2010cites this paper
• p53-Dependent Induction of Prostate Cancer Cell Senescence by the PIM1 Protein Kinase

  2010cites this paper
• Tumor microenvironment and progression of pancreatic cancer.

  2010cites this paper